Further to Imagion Biosystems Limited’s announcement dated 23 May 2018, the Company advises of an amendment to Resolution 9 of its Notice of Annual General Meeting dated 2 May 2018, which is detailed in the attached Notice of Amendment.
Save for as detailed in the Notice of Amendment, which will shortly be despatched to shareholders, all other aspects of the Notice of Annual General Meeting remain unchanged.
The Company’s Annual General Meeting will be held at 1.30pm (AEST) on Thursday, 31 May 2018 at the offices of Holding Redlich, Level 8, 555 Bourke Street, Melbourne, Victoria 3000.
Corporate Update – IND for MagSense® HER2 Phase 2 Study Immediate Priority
Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSense® HER2 Phase 2 Study Immediate Priority